Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jan Dolhain, Winnie Janssens, Vasundhara Dindore & Attila Mihalyi. (2020) Infant vaccine co-administration: review of 18 years of experience with GSK’s hexavalent vaccine co-administered with routine childhood vaccines. Expert Review of Vaccines 19:5, pages 419-443.
Read now
Read now
Articles from other publishers (16)
Young June Choe, Daniel B. Blatt, Hoan Jong Lee & Eun Hwa Choi. (2020) Associations between geographic region and immune response variations to pneumococcal conjugate vaccines in clinical trials: A systematic review and meta-analysis. International Journal of Infectious Diseases 92, pages 261-268.
Crossref
Crossref
Andrés Rosenblut, Macarena Rosenblut, Karen García, Ximena Maul & María E. Santolaya. (2018) Frequency of Acute Otitis Media in Children Under 24 Months of Age Before and After the Introduction of the 10-valent Pneumococcal Conjugate Vaccine Into the National Immunization Program in Chile. Pediatric Infectious Disease Journal 37:2, pages 132-134.
Crossref
Crossref
Aaradhana Singh & A. K. Dutta. (2017) Pneumococcal Vaccines – How Many Serotypes are Enough?. The Indian Journal of Pediatrics 85:1, pages 47-52.
Crossref
Crossref
Peng Zou, Yuan Li, Jinghe Huang & Fan Wu. (2017) Self-assembly polymerization enhances the immunogenicity of influenza M2e peptide. Microbes and Infection 19:12, pages 648-654.
Crossref
Crossref
Jeanet M. Kemmeren, Nicoline AT van der Maas & Hester E. de Melker. (2017) Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands. European Journal of Pediatrics 176:6, pages 757-768.
Crossref
Crossref
Melinda M. Pettigrew, Mark R. Alderson, Lauren O. Bakaletz, Stephen J. Barenkamp, Anders P. Hakansson, Kevin M. Mason, Johanna Nokso‐Koivisto, Janak Patel, Stephen I. Pelton & Timothy F. Murphy. (2017) Panel 6: Vaccines. Otolaryngology–Head and Neck Surgery 156:S4.
Crossref
Crossref
Andres Rosenblut, Carla Napolitano, Angelica Pereira, Camilo Moreno, Devayani Kolhe, Alejandro Lepetic & Eduardo Ortega-Barria. (2017) Etiology of acute otitis media and serotype distribution of Streptococcus pneumoniae and Haemophilus influenzae in Chilean children <5 years of age. Medicine 96:6, pages e5974.
Crossref
Crossref
Jorge A. Gómez, Alberto Villaseñor-Sierra, Gerardo Martínez Aguilar, Roberto Carreño Manjarrez & María Y. Cervantes-Apolinar. (2016) Estimación de la Relación Costo-Efectividad de las Vacunas Neumocócicas Conjugadas Prevenar-13 y Synflorix®, Utilizadas en Los Programas de Vacunación de Población Infantil Mexicana. Value in Health Regional Issues 11, pages 76-84.
Crossref
Crossref
Chinh C. Ngo, Helen M. Massa, Ruth B. Thornton & Allan W. Cripps. (2016) Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review. PLOS ONE 11:3, pages e0150949.
Crossref
Crossref
A. Torres, P. Bonanni, W. Hryniewicz, M. Moutschen, R. R. Reinert & T. Welte. (2014) Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?. European Journal of Clinical Microbiology & Infectious Diseases 34:1, pages 19-31.
Crossref
Crossref
Greg L. Plosker. (2014) 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine: A Review in Infants and Children. Pediatric Drugs 16:5, pages 425-444.
Crossref
Crossref
Daniel E. Park, T. Scott Johnson, Bareng Aletta S. Nonyane, Subhash Chandir, Laura Conklin, Katherine E. Fleming-Dutra, Jennifer D. Loo, David Goldblatt, Cynthia G. Whitney, Katherine L. O’Brien & Maria Deloria Knoll. (2014) The Differential Impact of Coadministered Vaccines, Geographic Region, Vaccine Product and Other Covariates on Pneumococcal Conjugate Vaccine Immunogenicity. Pediatric Infectious Disease Journal 33:Supplement 2, pages S130-S139.
Crossref
Crossref
Maria Deloria Knoll, Daniel E. Park, T. Scott Johnson, Subash Chandir, Bareng Aletta S. Nonyane, Laura Conklin, Katherine E. Fleming-Dutra, Jennifer D. Loo, David Goldblatt, Cynthia G. Whitney & Katherine L. O’Brien. (2014) Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Immunogenicity. Pediatric Infectious Disease Journal 33:Supplement 2, pages S119-S129.
Crossref
Crossref
Tran Ngoc Huu, Nguyen Trong Toan, Ha Manh Tuan, Ho Lu Viet, Pham Le Thanh Binh, Ta-Wen Yu, Fakrudeen Shafi, Ahsan Habib & Dorota Borys. (2013) Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial. BMC Infectious Diseases 13:1.
Crossref
Crossref
Gail L. Rodgers, Susanna Esposito, Nicola Principi, Maricruz Gutierrez-Brito, Javier Diez-Domingo, Andrew J. Pollard, Matthew D. Snape, Federico Martinón-Torres, William C. Gruber, Scott Patterson, Allison Thompson, Alejandra Gurtman, Peter Paradiso & Daniel A. Scott. (2013) Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. Vaccine 31:42, pages 4765-4774.
Crossref
Crossref
Guillermo M. Ruiz-Palacios, Li-Min Huang, Tzou-Yien Lin, Lorena Hernandez, M. Lourdes Guerrero, Antonio Lavalle Villalobos, Marie Van der Wielen, Marta Moreira, Laurence Fissette, Dorota Borys & Jacqueline M. Miller. (2013) Immunogenicity and Safety of a Booster Dose of the 10-valent Pneumococcal Haemophilus Influenzae Protein D Conjugate Vaccine Coadministered With the Tetravalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine in Toddlers. Pediatric Infectious Disease Journal 32:1, pages 62-71.
Crossref
Crossref